← BackTransMedics Group, Inc. · Electromedical & Electrotherapeutic ApparatusTMDX
Low riskNext report: In 1 days (est.)
The short versionA profitable company with growing sales. Institutions are trimming.
Going well
- Sales up 21% in the latest quarter vs a year ago
- Profitable, keeps 31% of sales as profit
- Sales up 37% last year
Watch out for
- Share count growing 11.1% a year (dilution)
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 4.3% from their holdings in the quarter ending June 2026 (203 bought, 228 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$70.57-0.1% that day
- Company value
- $2.4B
- Share price times all shares
- Price vs profit (P/E)
- 18.3x
- You pay about $18 for each $1 of yearly profit
- Price vs sales
- 3.7x
- Company value is 3.7 times a year of sales
- Cash vs value
- 20%
- Cash as a share of company value
- Debt vs value
- 0%
- Debt as a share of company value
From TMDX's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$189.9M+21% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $668.5M, up 26% from the 12 months before. Over 5 years, sales grew about 85% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- PassReturn on equity 15%+Earns a lot on the money owners have in the business.54.2%
- PassDebt under half of equityNot relying on borrowed money.0.02x equity
- PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.31.4%
- MissProfitable every yearSteady profits, not one good year.2 of 8 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$133.6M
- MissShare count not growingNot diluting owners. Falling means buybacks.+37.2% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.59.9%
- Revenue
- $605.5M
- +37.1% vs prior year
- 5-year growth
- +84.5%/yr
- revenue, per year
- Total debt
- $10.0M
- 0.02x equity
- Current ratio
- 7.14x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $189.9M
- +20.7% YoY
- EPS
- $0.41
- vs $0.92
- Op. margin
- 12.5%
- -10.7 pts
- Gross margin
- 59.6%
- -1.8 pts
- Free cash flow
- $10.2M
- Share count
- +0.4%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.5
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▼Distributing-4.3%Institutions cut 4.3% from their holdings. 203 bought, 228 sold. 3 quarters of net selling in a row.
Shares held by institutions34.8M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+2.0%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.9x · $454.3M debtShares outstandingLatest reported
35MNext reportIn 1 days (est.)Estimated from the same quarter last year
- Results filedAug 4
- Results filedMay 5
- Results filedFeb 27
- Results filedFeb 24
- Results filedOct 29, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
BoughtDavid WeillDirector
1,336 shares at $81.63 · $109K
- +9% of holdings
- Now owns 16,392 shares
- Filed 3 days after trade
GiftJames R TobinDirector
18,000 shares
- Owns no shares after
- Held by The Tobin 2024 Family Trust
- Filed same day
Stock awardWaleed H HassaneinPresident & CEO, Director
49,669 shares
- +41% of holdings
- Now owns 171,093 shares
- Exercise price $71.23
- Filed 4 days after trade
Stock awardGerardo HernandezChief Financial Officer
17,246 shares
- +117% of holdings
- Now owns 31,935 shares
- Exercise price $71.23
- Filed 4 days after trade
Stock awardNicholas CorcoranSee remarks
11,727 shares
- +39% of holdings
- Now owns 41,558 shares
- Exercise price $71.23
- Filed 4 days after trade
SoldThomas J. GundersonDirector
9,624 shares at $75.06 · $722K
- -37% of holdings
- Now owns 16,642 shares
- Not a pre-planned sale
- Filed 2 days after trade
- Also: Option exercise